Empowering you to save lives and uplift communities
Verification and EQA programs are essential for identifying errors, their causes and taking corrective actions for future testing. SmartSpot’s programs ensure participants, and the patients they serve, can have the highest possible level of confidence in their results.
Spots distributed globally
Global SmartSpot EQA Program
SmartSpot Quality is an ISO/IEC 17043:2010 accredited Proficiency Testing Scheme Provider
Award-winning diagnostic solutions
The SmartSpot patented technology enables the packaging of inactivated specimens on a simple spot on a card, which is easily and safely tested like a patient’s clinical specimen.
External Quality Assessment provides on-going quality monitoring of diagnostics, from pre- to post-analytical processing. SmartSpot Quality’s EQA Programs run three times per year per instrument.
Instrument verification involves testing standardized material on a diagnostic instrument to ensure that it is ‘fit-for-purpose’ before clinical specimens can be tested. Verification is recommended upon installation, post-calibration and post-relocation.
SmartSpot Quality provides the largest commercially available Molecular Mycobacterium Tuberculosis EQA program globally with instruments enrolled across 30 countries.
SmartSpot Quality provides the first non-infectious liquid Human Immuno-deficiency Virus EQA and Verification Control Program that is stable at ambient temperature.
SmartSpot has responded to the COVID-19 pandemic and provide a set of non-infectious and ambient temperature stable Quality Controls for molecular diagnostic SARS-CoV-2 assays.
Why our programs are industry leading
Controls are stable at ambient temperatures
for up to 24 months
reducing shipping by 67% and mitigating the risk of damage to the controls.
In-depth support to laboratories via video conferencing, providing technical guidance and general operational advice.
Online Quality Assessment Tool provided for submitting EQA and Verification results and reviewing performance.
2 week or real-time
turnaround for Participant Reports.
Group management reports
with analytics and insights.
Since the onset of widescale molecular testing for TB in 2010, SmartSpot has been developing controls to meet the quality needs of TB molecular laboratories across the globe. In 10 years, SmartSpot has developed a global footprint in 47 countries providing Ministries of Health, Clinical Trial Units and private laboratories with quality control solutions. SmartSpot is the largest commercial supplier of molecular TB controls and provides a companion diagnostic for qualifying the accuracy of molecular diagnostic tests including TB, HIV, SARS-CoV-2, and soon MRSA and HCV.